Not Signed In - Weekly Docetaxel And Prednisolone Versus Prednisolone Alone In Androgen-Independent Prostate Cancer: A Randomized Phase II Study
Mon, 05 Mar 2007 08:00 AM EST
... UroToday.com- In 2004 two large randomized clinical trials demonstrated that docetaxel based chemotherapy improved survival in androgen-independent prostate cancer (AICAP). In combination with prednisone, patients had improved quality of life and this is now the standard therapy for AICAP. [click link for full article] ...
Related Topics
- Clinical Trials
- Nystatin and Triamcinolone
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Kniest dysplasia
- Radiation Studies
- Juvenile Diabetes
- Membranoproliferative GN II
- Factor II deficiency
- Phenylephrine and Guaifenesin Capsules
- Cockayne Syndrome Type II
- Pena Shokeir II Syndrome
- Ramsay Hunt Syndrome Type II
- Multiple endocrine neoplasia (MEN) II
- Pseudoephedrine and Guaifenesin ER
- Collagenopathy, types II and XI
- PET Study
- Caregiving
- Diabetes
- Herpes Simplex
email this page
print this page
bookmark this page
feedback on this page
